Upcoming Conferences in the Life Sciences Industry
LSX Nordic Congress
It has been connecting life science and healthcare industry leaders with international investment and strategic partners to further the growth, development and internationalisation of Nordic life science and healthcare innovation since 2018.
The mission is to facilitate ever greater international investment into the region, as well as foster strategic partnerships and collaboration with key international healthcare stakeholders.
We are delighted to be hosting the 7th LSX Nordic Congress in Copenhagen, Denmark once again! As the hub of Medicon Valley, the crucible of Scandinavian life sciences, we can’t wait to welcome you all to Copenhagen in October!
BiotechX Europe 2024
In 2024 BioTechX will return to Basel, the pharma hub of Europe, this time with 3500 global executives, 400 speakers and 50 start-ups all under one roof, bridging the gap between pharma, academia and clinicians. Don't miss Europe's largest biotechnology congress for pharma, healthcare and partners.
For 50% off delegate tickets, use code BTG50
Free VIP guest link for Biotechgate members that fall into the buy side part of the conference
Representatives from Venture Valuation and Biotechgate will participate in BiotechX Europe 2024.
World Drug Safety Congress Europe
For 50% off delegate tickets, use code BTG50
Complimentary guest link for Government, NGOs, Patient Groups & Academics
Festival of Biologics Basel
World Orphan Drug Congress Europe
World Vaccine Congress Europe
BioFuture 2024
Representatives from Venture Valuation and Biotechgate will participate in BioFuture 2024.
AusBioInvest 2024
AusBioInvest, Australia’s premier life science investment conference, is dedicated to building meaningful connection between investors and private and publicly-listed biotech companies actively seeking investors or partners to support their funding and co-development.
The full-day programme will feature keynotes and panel sessions with leading investors and business leaders on the trends, themes, and market conditions shaping life science investing, in addition to up to 25 presentations from early to late-stage biotechnology companies seeking investment and strategic partners.
Investors also receive access to an exclusive networking lounge and AusPartnering, AusBiotech’s 1:1 business matching programme. Qualified investors are invited to register for a complimentary pass here »
Representatives from Venture Valuation and Biotechgate will participate in AusBioInvest 2024.
AusBiotech 2024 National Conference
AusBiotech 2024 features an industry-led programme with more than 170 speakers across over 60 sessions developed to inform, educate, celebrate, and inspire the life science community. AusBiotech 2024 is created by industry, for industry. This year's programme features a one-day AgriBiotech Summit, the Early-Stage Innovation Forum rapid-fire pitch competition, conference gala dinner, and plenty of formal and informal networking opportunities.
For over 38 years, the AusBiotech conference has been the premier international meeting place for the Australian life science community, attracting delegates from over 20 countries. Learn from international and local thought leaders as they discuss the latest research, technologies, challenges, opportunities, and market access strategies.
Engage in in-person networking, cutting-edge programming, and be part of advancing the life sciences industry during the flagship event of ‘Australia’s biggest week in biotech’.
Register here »
Representatives from Venture Valuation and Biotechgate will participate in AusBiotech 2024 National Conference.
BIO-Europe® 2024
Over the last 30 years, BIO-Europe, has become Europe’s flagship partnering event. Its international reach makes it a one-of-a-kind offering, with attendees from all parts of the biotechnology value chain gathering to efficiently identify, engage and form strategic relationships that drive their businesses successfully forward.
BIO-Europe delivers for all the players of the biopharma community, providing startup and innovator programmes, insights on industry trends from KOLs, the gold standard of partnering systems as well as ample serendipitous networking opportunities. The combination of activities and the combination of participants delivers an unprecedented ROI.
Representatives from Venture Valuation and Biotechgate will participate in BIO-Europe® 2024.
Advanced Therapies USA
Inv€$tival Showcase
With 7 incredible presenting stages for startup, growth stage and publicly listed Biotech, Healthtech, Medtech, TechBio, Digital Health and Deeptech companies.
The LSX Investival Showcase continues its exclusive partnership with global investment bank Jefferies, serving as the kick off to Jefferies week, leading into the Jefferies London Healthcare Conference.
Pre-JPM Partnering Week
Representatives from Venture Valuation and Biotechgate will participate in Pre-JPM Partnering Week.
8th Annual Neuroscience Innovation Forum
Positioned at the beginning of JPM week, the NIF forum focuses on the latest developments across key areas of neuroscience, which are currently attracting record investor interest and deal flow. The main programme for the 8th Annual NIF will feature more than 8 hours of high-level keynotes and panel discussions addressing the important advances in therapeutic, neurotech, and diagnostics fields.
RESI JPM 2025
Representatives from Venture Valuation and Biotechgate will participate in RESI JPM 2025.